Skip to main content
Premium Trial:

Request an Annual Quote

Gene Network Offers Biosimulation in Clinical Setting

NEW YORK, Nov. 30 (GenomeWeb News) - Gene Network Sciences will provide computer models to improve clinical trial success rates for cancer patients at the Mary Crowley Medical Research Center, the company said today.

 

Under the partnership agreement, Gene Network will be compensated per-patient.

 

The Dallas, TX-based medical facility will use biosimulation to test which therapies have the best clinical outcomes based on actual cancer patients' individual gene-expression data, the company said.

 

Gene Network processes biological data to develop computer simulations of cells, tissues, and organs for the purpose of improving cancer drug research and patient treatment, the firm said. By filtering out drug candidates in computer models fed with patient data, specialists may be able to better identify better drugs.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.